Novation signs on Oncura as second brachytherapy supplier:
This article was originally published in Clinica
Oncura, the Plymouth Meeting, Pennsylvania-based prostate cancer treatment company, has won a three-year deal to supply US group purchasing organisation Novation with its portfolio of Iodine-125 and Palladium-103 prostate brachytherapy products. The agreement takes effect immediately. Novation has also taken on Chatsworth, California-based North American Scientific as its brachytherapy products supplier (see Clinica No 1207, p 18).